Background The clinical utility of serum procalcitonin levels in guiding antibiotic treatment
decisions in patients with sepsis remains unclear. This patient-level meta-analysis based on …

Sepsis is characterized by complex pathophysiology and heterogeneous phenotypes of
affected patients regarding their symptoms, response to treatment, and outcomes. At present …

Summary Background In February, 2017, the US Food and Drug Administration approved
the blood infection marker procalcitonin for guiding antibiotic therapy in patients with acute …

Herein a label-free immunosensor based on electrolyte-gated organic field-effect transistor
(EGOFET) was developed for the detection of procalcitonin (PCT), a sepsis marker …

Sepsis remains a leading cause of maternal morbidity and mortality. Recognition and
treatment of maternal sepsis are often delayed due to the physiological adaptations of …

Background: Procalcitonin (PCT) is a useful biomarker of bacterial infection and its use is
associated to reduced duration of antibiotic therapy in the setting of intensive care medicine …

The purpose of this study was to confirm the prognostic value of pentraxin-3 (PTX3),
procalcitonin (PCT) and lactate in patients with severe infections requiring ICU management …

Background Procalcitonin (PCT) is a valuable prognostic biomarker in human sepsis that is
predictive of organ dysfunction, septic shock and mortality. Data on PCT in dogs is limited …

Background Sepsis management guidelines endorse use of biomarkers to support clinical
assessment and treatment decisions in septic patients. The impact of biomarkers on …

Background Early sepsis diagnosis is crucial for the correct management of burn patients,
and it clearly influences outcomes. The systemic inflammatory response triggered by burns …